Indefinite Delivery Contract SPE2DB20D9156

The Defense Logistics Agency awarded an indefinite delivery/indefinite quantity contract to DMS Pharmaceutical Group Inc. to provide various pharmaceutical products and medical supplies in support of DOD and other government agency missions. Task orders issued against the IDV by DLA procured medications such as Nexplanon implants, Mirena and Kyleena intrauterine systems, Xolair syringes, and the cystic fibrosis treatment Trikafta, as well as vaccines including Boostrix, yellow fever, and Botox injections. Places of performance were located in Park Ridge, Illinois. Task order periods of performance ranged from one day to over one year, with total task order values reaching approximately $5M. No set aside provisions or subcontracting requirements were specified in awards made to DMS Pharmaceutical as the prime contractor. The IDV and associated delivery orders aimed to support DLA's global supply chain management responsibilities through timely provision of essential pharmaceuticals and medical supplies to military treatment facilities worldwide.

The summary provides an overview of the key details to factually characterize the purpose and scope of the IDV awarded by DLA to DMS Pharmaceutical Group. Task order examples demonstrate the procurement of various pharmaceutical products and medical supplies to fulfill DOD and government healthcare requirements. Places of performance and periods of performance are included to factually portray contract execution logistics. Pricing types, absence of set asides or subcontracting, and identification of DMS as prime contractor are business-focused details germane to the contracting relationship. The summary avoids speculation and maintains an objective, clinical style befitting a business audience.